April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Called garnish, which is useful every day Aug 9, 2020
- Zack Snyder had a cameo in Army of the Dead! May 30, 2021
- Rennes: The biggest fest-noz in the world returns after two years of absence Nov 19, 2022
- Covid vaccine, Bassetti: “Third dose at the end of the year, perhaps for some it is late” Aug 27, 2021
- Unvaccinated EU citizens face risk of job loss Jun 29, 2021
- Medicine Test 2021: between news and confirmations Aug 5, 2021
- Covid, Pregliasco: “I don’t see a bad vaccine requirement for teachers” Jul 17, 2021
Maxie Eckert
Today at 11:34 AM
.
